About the Company
We do not have any company description for Vivani Medical, Inc. at the moment.
Sector
Industrial Applications and Services
Industry
Electromedical & Electrotherapeutic Apparatus
Employees
25
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Vivani Medical, Inc.
Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results
Company plans rapid advancement of semaglutide implant NPM-139, following positive weight loss data from an ongoing ...
Vivani Medical Reports Q2 2025 Results and $10M Financing
Vivani Medical, Inc. ( (VANI) ) has released its Q2 earnings. Here is a breakdown of the information Vivani Medical, Inc. presented to its investors.Elevate Your Investing Strategy: Take advantage of ...
Vivani Medical Secures $10M Through Share Purchase Agreement
Vivani Medical ( ($VANI) ) has shared an update. On August 11, 2025, Vivani Medical entered into a Share Purchase Agreement to sell 7,936,507 ...
Vivani Medical Provides Business Update Including $3M ... - Morningstar
ALAMEDA, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a biopharmaceutical company developing miniaturized, ultra long-acting ...
Vivani Medical Inc News (VANI) - Investing.com
Vivani Medical, Inc. receives Investment Bank Analyst Rating Update ByInvesting.com •Jun 08, 2023 Vivani Medical Wins $1M NIH Grant Funding to Support Cortigent’s Ongoing Orion Clinical Study ...
Vivani Medical Appoints Anthony Baldor as Chief Financial Officer
Investor Relations Advisor investors@vivani.com (415) 506-8462 Media Contact: Sean Leous ICR Healthcare Sean.Leous@ICRHealthcare.com (646) 866-4012 Source: Vivani Medical, Inc. 2025 GlobeNewswire ...
VANIW Vivani Medical, Inc. WT EXP 031424 - Seeking Alpha
A high-level overview of Vivani Medical, Inc. WT EXP 031424 (VANIW) stock. View (VANIW) real-time stock price, chart, news, analysis, analyst reviews and more.
Vivani Medical to Present at the 2025 BIO International Convention
ALAMEDA, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), a clinical-stage biopharmaceutical company developing miniature, ultra ...
EXCLUSIVE: Vivani Medical Announces First Implant In Early-Stage Human ...
On Thursday, Vivani Medical, Inc. (NASDAQ:VANI) announced the administration of its first GLP-1 (exenatide, NPM-115) implant in the LIBERATE-1 trial in Australia. Vivani's lead program, NPM-115 ...
Vivani Medical Announces Pricing of $15.0 Million Registered ... - Nasdaq
Vivani Medical, Inc., an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, today announced that it has entered into a securities purchase agreement ...
Vivani Medical Short Interest Report - Benzinga
Short interest in Vivani Medical Inc (NASDAQ:VANI) increased during the last reporting period, rising from 295.36K to 345.39K. This put 0.96% of the company's publicly available shares short.
Similar Companies
Loading the latest forecasts...